Home > Product > APIs > Bivalirudin Trifluoroacetate

APIs

warning All products are for research use only. Not for human use.

Bivalirudin Trifluoroacetate

[Price Inquiry]
CAT#
10-101-06
Synonyms/Alias
BG 8967; Hirulog; Hirulog I; Bivalirudin; Angiomax; Hirulog-1; Hirulog1; Hirulog 1; BG8967; BG 8967; BG-8967; LS-172701; LS172701; LS 172701
CAS No.
128270-60-0 (net)
Sequence
H-D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH trifluoroacetate salt
M.W/Mr.
2108.3
Molecular Formula
C98H138N24O33
Source
Synthetic
Long-term Storage Conditions
−20°C
Application
Bivalirudin is a hirudin analog. It acts as a specific and reversible direct thrombin inhibitor.
Description
Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors. It is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin. Bivalirudin inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. It has a quick onset of action and a short half-life, without binding to plasma proteins (other than thrombin) or red blood cells. Therefore it has a predictable antithrombotic response.
Areas of Interest
Antithrombotic therapy
Home | Site Map | Contact Us | Resources
Copyright © 2008 - 2016 Creative Peptides. All rights reserved.